Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy

Condition:   Nasopharyngeal Carcinoma
Intervention:   Drug: Nivolumab
Sponsor:   The University of Hong Kong
Not yet recruiting

http://ift.tt/2ApTcC6